After an already tough year, earnings and guidance are expected to come under increased pressure. Yet there are names that stand out in this environment, according to Wolfe Research. The firm came up with a list of names to hold for the long term based on their earnings performances and forecasts this year.
Pepsi also boosted its forecast, anticipating revenue growth of 12% for 2022, up from 10%. CVS Health doesn't report its third-quarter results until Nov. 2, but in its second-quarter report , the company increased its earnings outlook for 2022. The pharmacy operator now expects earnings per share for the full year to come in between $8.40 and $8.60, compared with its earlier estimate of between $8.20 and $8.40. In the second quarter, the company earned $2.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »